This collective experience provides valuable guidance beyond marketing materials
Curr Opinion Pharmacol 4:378385 Edelstein R, Tamanaha C, Sheehan P, Miller M, Baselt D, Whitman L, Colton R (2000) The BARC biosensor applied to the detection of biological warfare agents
Reconstitution activates the compound by dissolving it in bacteriostatic water, which introduces molecular mobility and oxidation pathways
In some embodiments, the lipid-based drug delivery formulation is a phospholipid-based formulation (e.g., hydrogenated or nonhydrogenated phospholipids, lecithins, phosphatidyl cholines (C8-C18), phosphatidylethanolamines (C8-C18), phosphatidylglycerols (C8-C18)) wherein the phospholipid is phospholipon 90H (1,2-dia-cyl-SN-glycero-3-phosphatidyl choline), egg phospholipids P123, Lipoid E80
About this article Cite this article Melnik, B.C., John, S.M